Ocuphire Pharma Inc (OCUP)
$0.00 $0.00 (0.00%) 4:37 PM 12/10/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$31.74M -
Day's Range
- - - -
Volume
139,765 -
52 Week Low / High
$1.07 - $3.40 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
OCUP's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 3
- Strong Buy
- 1
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $20.20
- Target Price
Company News
-
Ocuphire Announces the U.S. Commercial Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution 0.75%) by its Partner Viatris — Apr 1st, 2024
Ocuphire Pharma FARMINGTON HILLS, Mich., April 01, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of unmet needs of patients with retinal and refractive eye disorders, today ...
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$